Clicky

Saturday, November 21, 2026
PFE · NYSE

PFIZER INC

2834 Pharmaceutical Preparations. Large accelerated filer. New York, NY.

Revenue

$62.58B

Earnings

$7.77B

Diluted EPS

$1.36

Profit margin

12.4%

News on PFE

Pfizer reveals $164 million in biotech holdings in 13F-HR

Pfizer Inc. discloses $164 million in biotech investments in its recent 13F-HR filing, emphasizing its strategic focus on pharmaceutical preparations.

Pfizer appoints Cecile Guegan as Chief Financial Officer

Pfizer Inc. announces Cecile Guegan as new CFO, effective November 1, 2026, highlighting her extensive experience in the pharmaceutical industry.

Pfizer reports Q3 results, highlights financial performance

Pfizer Inc. releases Q3 financial results, showcasing key metrics and strategies in the pharmaceutical sector, impacting competitors and market dynamics.

Pfizer reports third-quarter financial results for 2026

Pfizer Inc. announces its financial results for Q3 2026, reflecting ongoing developments in the pharmaceutical preparations sector.

Revenue and earnings

20182019202020212022202320242025

Earnings trend

Q3 2018Q1 2019Q2 2019Q1 2024Q2 2024
PeriodRevenueEarningsDiluted EPSRevenue vs year agoEarnings vs year ago
Q2 2024$13.28B$41.00M$0.01——
Q1 2024$14.88B$3.12B$0.55——
Q2 2019$13.26B$5.05B$0.89——
Q1 2019$13.12B$3.88B$0.68——
Q3 2018$13.30B$4.11B$0.69——

Income statement

20212022202320242025
Revenue$81.29B$101.17B$59.55B$63.63B$62.58B
Interest expense$1.29B$1.24B$2.21B$3.09B$2.67B
Income tax$1.85B$3.33B-$1.11B-$28.00M-$266.00M
Earnings$21.98B$31.37B$2.12B$8.03B$7.77B
Diluted EPS$3.85$5.47$0.37$1.41$1.36

Balance sheet

20212022202320242025
Cash$1.94B$416.00M$2.85B$1.04B$1.14B
Current assets$59.69B$51.26B$43.33B$50.36B$42.90B
Total assets$181.48B$197.21B$226.50B$213.40B$208.16B
Current liabilities$42.67B$42.14B$47.79B$42.99B$36.98B
Long-term debt$36.20B$32.88B$61.54B$57.41B$61.64B
Total liabilities$104.01B$101.29B$137.21B$124.90B$121.39B
Stockholders equity$77.20B$95.66B$89.01B$88.20B$86.48B

Cash flow

20212022202320242025
Cash from operations$32.58B$29.27B$8.70B$12.74B$11.70B
Cash from investing-$22.55B-$15.78B-$32.28B$2.65B-$1.35B
Cash from financing-$9.82B-$14.83B$26.07B-$17.14B-$10.30B
Capital spending$2.71B$3.24B$3.91B$2.91B$2.63B

Statistics

20212022202320242025
Revenue growth+95.2%+24.5%-41.1%+6.8%-1.6%
Earnings growth+140.0%+42.7%-93.2%+279.0%-3.2%
Profit margin27.0%31.0%3.6%12.6%12.4%
Current ratio1.401.220.911.171.16

Filings

DateFilingDescriptionOur story
October 16, 2026 4 4
October 14, 2026 4 4
October 1, 2026 4 4
September 29, 2026 4 4
September 29, 2026 4 4
September 29, 2026 4 4
September 29, 2026 4 4
September 29, 2026 4 4
September 29, 2026 4 4
September 16, 2026 4 4
September 1, 2026 4 4
August 28, 2026 3 3
August 17, 2026 4 4
August 12, 2026 4 4
August 6, 2026 4 4
August 5, 2026 4 4
August 5, 2026 4 4
August 4, 2026 10-Q 10-Q
August 4, 2026 8-K 8-K. Items 2.02,9.01
August 3, 2026 4 4
July 16, 2026 4 4
July 13, 2026 4 4
July 1, 2026 4 4
June 30, 2026 4 4
June 30, 2026 4 4
June 30, 2026 4 4
June 30, 2026 4 4
June 30, 2026 4 4
June 30, 2026 4 4
June 18, 2026 8-K 8-K. Items 7.01
June 18, 2026 8-K 8-K. Items 5.02,9.01
June 16, 2026 4 4
June 10, 2026 4 4
June 1, 2026 4 4
May 18, 2026 4 4
May 5, 2026 10-Q 10-Q
May 5, 2026 8-K 8-K. Items 2.02,9.01
May 4, 2026 4 4
April 27, 2026 8-K 8-K. Items 5.07
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 27, 2026 4 4
April 17, 2026 4 4
April 16, 2026 4 4
April 10, 2026 3 3
April 1, 2026 4 4
March 30, 2026 4 4
March 30, 2026 4 4
March 30, 2026 4 4
March 30, 2026 4 4
March 30, 2026 4 4
March 30, 2026 4 4
March 16, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 5, 2026 4 4
March 3, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 27, 2026 4 4
February 26, 2026 10-K 10-K
February 24, 2026 4 4
February 24, 2026 4 4
February 17, 2026 4 4
February 3, 2026 8-K 8-K. Items 2.02,9.01
February 2, 2026 4 4
January 16, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4
January 5, 2026 4 4

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →